Changchun BCHT Biotechnology Co. (SHA:688276)

China flag China · Delayed Price · Currency is CNY
17.28
-0.34 (-1.93%)
May 20, 2026, 11:29 AM CST
Market Cap7.29B -18.8%
Revenue (ttm)590.13M -47.4%
Net Income-267.12M
EPS-0.65
Shares Out413.66M
PE Ration/a
Forward PEn/a
Dividend0.17 (0.98%)
Ex-Dividend DateJun 18, 2025
Volume714,453
Average Volume2,160,198
Open17.52
Previous Close17.62
Day's Range17.21 - 17.61
52-Week Range17.05 - 26.30
Beta0.15
RSI39.13
Earnings DateApr 22, 2026

About SHA:688276

Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. The company’s products include herpes zoster vaccine; varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and rabies vaccine (vero cell) for humans. Changchun BCHT Biotechnology Co. Ltd. was founded in 2004 and is based in Changchun, China. [Read more]

Sector Healthcare
Founded 2004
Employees 1,252
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688276
Full Company Profile

Financial Performance

Financial Statements